Patent On AIDS Drug Will Not Limit Access In India, Industry Argues 30/03/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment It is “misleading” and “counter-productive” to assert that a pharmaceutical company’s filing for a patent on a HIV/AIDS drug in India will limit access to the drug in the future, GlaxoSmithKline said in response to an objection submitted today in India. The comment is a response to the submission of a “pre-grant opposition” to the […]
Protest Submitted To First Patent Filing Of HIV/AIDS Drug In India 30/03/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment Two Indian HIV/AIDS networks and an international group of lawyers today submitted a protest to the first application for a patent for an HIV/AIDS drug filed in India. The opportunity to stage a “pre-grant opposition” is the “beauty of the Indian patent system,” said Ellen ‘t Hoen of Médecins Sans Frontières (MSF) in an interview. […]
Public Health And Patents Heat Up WIPO Debate On Harmonisation 08/03/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment Discussions at an open forum last week on a possible harmonisation of international patent laws showed that countries do not only disagree on whether it would be useful or not but also have different expectations on what such a harmonisation would encompass. Judging from the at times sharp debate, the most contentious issue seems to […]
Biotech Industry Fights Disclosure In Patents On Three IP Policy Fronts 02/03/2006 by William New, Intellectual Property Watch Leave a Comment For the coming months, key biotechnology industry organisations are focusing their efforts on blocking the addition of disclosure of origin requirements in international patent applications on three fronts. The issue is being debated in three international fora: the World Trade Organization, the World Intellectual Property Organization and the Convention on Biological Diversity. Industry is mustering […]
La industria se prepara para un segundo round de la Directiva de la UE sobre patentes 14/02/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment Por William New PRAGA- Aquellas industrias dependientes de patentes que llevaron a cabo una costosa labor de cabildeo para tratar de obtener la aprobación de una directiva en materia de patentabilidad de invenciones relacionadas con computadores están aprendiendo de sus errores mientras se preparan para la posible resurrección de la cuestión. Los grupos de presión […]
Industry Readies For Round Two Of EU Patent Directive 19/01/2006 by William New, Intellectual Property Watch 5 Comments Prague — Patent-dependent industries that spent heavily for lobbying on a failed directive on the patentability of computer-related inventions are learning from their mistakes as they prepare for the possible resurrection of the issue. Lobbyists attending a Progress and Freedom Foundation (PFF) in Prague on 17 January signalled they will move early on the patent […]
Gilead Ends Patent Dispute With Roche Over Tamiflu 16/11/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment The US biopharmaceutical company Gilead Sciences has ended its dispute with the Swiss pharmaceutical company Roche regarding the right to the anti-influenza drug, Tamiflu (oseltamivir) “in the interest of working together to address public health needs,” Gilead announced today. Tamiflu is widely sought for use against the potential spread of avian influenza in humans. The […]
WHO: Patents Won’t Block Access To Avian Flu Medicines 10/11/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment The World Health Organisation does not think patents will stand in the way of an effective public health action in the event of an outbreak of avian flu in humans because pharmaceutical companies have showed a willingness to co-operate, a senior UN official said on 9 November. Margaret Chan, the WHO director-general’s representative for pandemic […]
Asamblea de la OMPI renueva el Programa para el Desarrollo, Debates sobre patentes 10/11/2005 by William New, Intellectual Property Watch 1 Comment Octubre de 2005 Los Estados miembros de la Organización Mundial de la Propiedad Intelectual dieron nuevas órdenes de marcha al organismo de Naciones Unidas en áreas fundamentales de programas, presupuesto y administración. Los representantes de más alto nivel de los países ante la OMPI eludieron los asuntos más difíciles, y trataron más bien de encontrar […]
New Committee For WIPO Development Agenda; Patents Reinvigorated 03/10/2005 by William New, Intellectual Property Watch 1 Comment Member governments of the World Intellectual Property Organisation tonight overcame a flare-up in tensions to reach agreement on the future of a proposed WIPO development agenda and the future work of a key patent committee. The final texts of both, which represent the last two sticking points for the 10-day WIPO General Assembly, will be […]